UKTIS

Best Use of Medicines in Pregnancy You can access our patient information leaflets at www.medicinesinpregnancy.org Our reporting facility offers all pregnant women, or women who have been pregnant in the past, the option to create their own password protected ‘my bumps record’ Create a record



This website is currently being updated Latest UKTIS updates COVID-19 antiviral registry

How to report medication exposure in pregnancy

Report your own pregnancy by creating your own ‘my bumps’
pregnancy record here

Healthcare professionals can report all pregnancy exposures to
UKTIS here

Accessing UKTIS pregnancy information

UKTIS abstracts are openly available here

Full scientific reviews for healthcare professionals are available
via www.toxbase.org

BUMPS - Patient information leaflets available here.

Coronavirus (COVID-19)

Tocilizumab shortage – UKTIS Official Position Statement;
sarilumab a possible treatment option

UKTIS have produced a review regarding the fetal and
neonatal risks of exposure to treatments which
are being used to treat covid-19

Information regarding COVID-19 vaccine can be found
here (Non-live vaccines)

Ondansetron update

UKTIS Response Statement - Ondansetron Use in Pregnancy

Open access - Ondansetron Systematic Evidence Review

Ondansetron use in pregnancy patient information leaflet

This page last updated 06/12/2021